CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
Status:
Completed
Trial end date:
2017-10-25
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies, such as CC-4047, may stimulate the immune system in
different ways and stop cancer cells from growing. Dexamethasone and CC-4047 may stop the
growth of cancer cells by blocking blood flow to the cancer. Giving CC-4047 together with
dexamethasone may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving CC-4047 together with dexamethasone
works in treating patients with relapsed or refractory multiple myeloma or amyloidosis.